ClinConnect ClinConnect Logo
Search / Trial NCT06513702

To Determine the Effectiveness of Transesophageal Lung Ultrasound Guided Recruitment Maneuver in Cardiac Surgery

Launched by UNIVERSITY OF MALAYA · Jul 16, 2024

Trial Information

Current as of July 23, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a new technique called Transesophageal Lung Ultrasound (TELUS) to help improve lung function during cardiac surgery, specifically coronary artery bypass surgery. The goal is to see if using this ultrasound method can reduce a condition known as lung atelectasis, which is when parts of the lung collapse and can cause breathing problems after surgery. Patients who participate will be randomly assigned to either receive the TELUS-guided technique or standard care during their surgery.

To be eligible for this trial, participants should be between 18 and 70 years old, scheduled for elective cardiac surgery that involves a special kind of heart test called transesophageal echocardiography (a type of ultrasound for the heart). They should also have a certain level of heart function and a specific risk score for surgery. However, individuals who are pregnant, have certain medical conditions affecting their lungs, or have had previous lung surgeries may not be eligible. This trial is not yet recruiting participants, so if you or someone you know is interested, keep an eye out for updates!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Age between 18 to 70 years old.
  • 2. Elective cardiac surgery that requires used of transoesophageal ECHO.
  • 3. New York Heart Association class I or II or III
  • 4. Preoperative LV ejection fraction \>40%
  • 5. European System for Cardiac Operative Risk Evaluation (Euroscore) 1-6
  • Exclusion Criteria:
  • 1. Pregnancy
  • 2. Contraindication to transoesophageal ECHO - oesophageal tumour, stricture, diverticulum, or recent oesophageal or gastric surgery
  • 3. Previous lung surgery/ history of lung radiation for cancer
  • 4. Severe obstructive/ restrictive lung disease- Examples: Patient with home CPAP, frequent hospitalization and ICU admissions due to lung disease
  • 5. BMI \<20, \> 35
  • 6. Patient needed for re-do surgery.
  • 7. Patient on ventricular assist device.

About University Of Malaya

The University of Malaya, a premier research institution in Malaysia, is dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, the University collaborates with leading healthcare professionals and researchers to explore cutting-edge treatments and interventions. Its clinical trial programs focus on various health challenges, aiming to translate scientific discoveries into practical applications that benefit diverse populations. By fostering a multidisciplinary approach, the University of Malaya continues to contribute significantly to the global medical research landscape.

Locations

Patients applied

0 patients applied

Trial Officials

Mohd Fitry bin Zainal Abidin

Principal Investigator

Consultant Anaesthesiologist Universiti Malaya Medical Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported